SCHEMBL29893853

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	10/20	0.58

▸	ECE1	P42892	1/20	0.58

▸	MUS81	Q96NY9	1/20	0.58

▸	KISS1R	Q969F8	5/20	0.57

▸	EDNRA	P25101	1/20	0.57

▸	SLC2A1	P11166	2/20	0.55

▸	GCGR	P47871	1/20	0.55

▸	GIPR	P48546	1/20	0.55

▸	PTH1R	Q03431	1/20	0.54

▸	IL23R	Q5VWK5	1/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30763298	0.95	GLP1R (0.61)	GLP1RECE1MUS81KISS1RGCGR
SCHEMBL31053397	0.95	GLP1R (0.61)	GLP1RECE1MUS81KISS1RGCGR
SCHEMBL29894848	0.95	GLP1R (0.60)	GLP1RECE1MUS81KISS1RGCGR
SCHEMBL31622727	0.95	GLP1R (0.61)	GLP1RECE1MUS81KISS1RGCGR
SCHEMBL31622725	0.94	GLP1R (0.57)	GLP1RECE1MUS81KISS1REDNRA
SCHEMBL30543287	0.92	PTH1R (0.57)	GLP1RECE1MUS81KISS1REDNRA
SCHEMBL31279646	0.92	PTH1R (0.57)	GLP1RECE1MUS81KISS1REDNRA
SCHEMBL30860128	0.91	GLP1R (0.60)	GLP1RECE1MUS81KISS1RGCGR
SCHEMBL31743242	0.91	GLP1R (0.61)	GLP1RECE1MUS81KISS1RGCGR
SCHEMBL30860116	0.91	GLP1R (0.60)	GLP1RECE1MUS81KISS1RGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4291647-B1	SUBTILISIN VARIANTS AND THEIR USE	FRESENIUS KABI IPSUM S R L (IT)	2025-06-18	—	—	EP	claimed
US-20220265551-A1	FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES	ZEALAND PHARMA A/S (DK)	2022-08-25	—	—	US	claimed